Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation

被引:228
|
作者
Guo, Yutao [1 ]
Lane, Deirdre A. [2 ,3 ,4 ]
Wang, Limin [5 ]
Zhang, Hui [1 ]
Wang, Hao [1 ]
Zhang, Wei [6 ]
Wen, Jing [7 ]
Xing, Yunli [8 ]
Wu, Fang [9 ]
Xia, Yunlong [10 ]
Liu, Tong [11 ]
Wu, Fan [12 ]
Liang, Zhaoguang [13 ]
Liu, Fan [14 ]
Zhao, Yujie [15 ]
Li, Rong [16 ]
Li, Xin [17 ]
Zhang, Lili [18 ]
Guo, Jun [1 ]
Burnside, Girvan [19 ]
Chen, Yundai [1 ]
Lip, Gregory Y. H. [1 ,2 ,3 ,4 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Med Sch Chinese PLA, Dept Cardiol, Beijing, Peoples R China
[2] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[3] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
[4] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark
[5] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China
[6] Chinese Peoples Liberat Army Gen Hosp, Seventh Clin Ctr, Dept Gerontol & Geriatr Med, Beijing, Peoples R China
[7] Haidian Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China
[8] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China
[9] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Gerontol & Geriatr Med, Sch Med, Shanghai, Peoples R China
[10] Dalian Med Univ, Dept Cardiol, Affiliated Hosp 1, Dalian, Peoples R China
[11] Tianjin Med Univ, Tianjin Inst Cardiol, Tianjin Key Lab Ion Mol Funct Cardiovasc Dis, Hosp 2, Tianjin, Peoples R China
[12] Tianjin Med Univ, Tianjin Geriatr Inst, Dept Geriatr, Gen Hosp, Tianjin, Peoples R China
[13] Haerbing Med Univ, Dept Cardiol, Affiliated Hosp 1, Haerbing, Peoples R China
[14] Hebei Med Univ, Dept Cardiol, Hosp 2, Shijiazhuang, Hebei, Peoples R China
[15] Southern Med Univ, Dept Cardiol, Henan Cardiovasc Hosp, Zhengzhou, Henan, Peoples R China
[16] Guangzhou Univ Chinese Med, Dept Cardiol, Affiliated Hosp 1, Guangzhou, Peoples R China
[17] Nanjing Med Univ, Benq Med Ctr, Dept Cardiol, Nanjing, Peoples R China
[18] Longhua Peoples Hosp, Dept Cardiol, Shenzhen, Peoples R China
[19] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England
基金
中国国家自然科学基金;
关键词
adverse events; atrial fibrillation; integrated care; mobile health; ORAL ANTICOAGULATION; AF; MANAGEMENT; GUIDELINE; WARFARIN; THERAPY; STROKE; TRENDS;
D O I
10.1016/j.jacc.2020.01.052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Current management of patients with atrial fibrillation (AF) is limited by low detection of AF, non-adherence to guidelines, and lack of consideration of patients' preferences, thus highlighting the need for a more holistic and integrated approach to AF management. OBJECTIVE The objective of this study was to determine whether a mobile health (mHealth) technology-supported AF integrated management strategy would reduce AF-related adverse events, compared with usual care. METHODS This is a cluster randomized trial of patients with AF older than 18 years of age who were enrolled in 40 cities in China. Recruitment began on June 1, 2018 and follow-up ended on August 16, 2019. Patients with AF were randomized to receive usual care, or integrated care based on a mobile AF Application (mAFA) incorporating the ABC (Atrial Fibrillation Better Care) Pathway: A, Avoid stroke; B, Better symptom management; and C, Cardiovascular and other comorbidity risk reduction. The primary composite outcome was a composite of stroke/thromboembolism, all-cause death, and rehospitalization. Rehospitalization alone was a secondary outcome. Cardiovascular events were assessed using Cox proportional hazard modeling after adjusting for baseline risk. RESULTS There were 1,646 patients allocated to mAFA intervention (mean age, 67.0 years; 38.0% female) with mean follow-up of 262 days, whereas 1,678 patients were allocated to usual care (mean age, 70.0 years; 38.0% female) with mean follow-up of 291 days. Rates of the composite outcome of 'ischemic stroke/systemic thromboembolism, death, and rehospitalization' were lower with the mAFA intervention compared with usual care (1.9% vs. 6.0%; hazard ratio [HR]: 0.39; 95% confidence interval [CI]: 0.22 to 0.67; p < 0.001). Rates of rehospitalization were lower with the mAFA intervention (1.2% vs. 4.5%; HR: 0.32; 95% CI: 0.17 to 0.60; p < 0.001). Subgroup analyses by sex, age, AF type, risk score, and comorbidities demonstrated consistently lower HRs for the composite outcome for patients receiving the mAFA intervention compared with usual care (all p < 0.05). CONCLUSIONS An integrated care approach to holistic AF care, supported by mHealth technology, reduces the risks of rehospitalization and clinical adverse events. (Mobile Health [mHealth] technology integrating atrial fibrillation screening and ABC management approach trial; ChiCTR-OOC-17014138). (C) 2020 by the American College of Cardiology Foundation.
引用
收藏
页码:1523 / 1534
页数:12
相关论文
共 50 条
  • [1] Mobile health technology in atrial fibrillation
    Bonini, Niccolo
    Vitolo, Marco
    Imberti, Jacopo Francesco
    Proietti, Marco
    Romiti, Giulio Francesco
    Boriani, Giuseppe
    Paaske Johnsen, Soren
    Guo, Yutao
    Lip, Gregory Y. H.
    [J]. EXPERT REVIEW OF MEDICAL DEVICES, 2022, 19 (04) : 327 - 340
  • [2] Mobile health technology facilitates population screening and integrated care management in patients with atrial fibrillation
    Guo, Yutao
    Lane, Deirdre A.
    Chen, Yundai
    Lip, Gregory Y. H.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 (17) : 1617 - 1619
  • [3] Transforming the care of atrial fibrillation with mobile health
    Mintu P. Turakhia
    Daniel W. Kaiser
    [J]. Journal of Interventional Cardiac Electrophysiology, 2016, 47 : 45 - 50
  • [4] Transforming the care of atrial fibrillation with mobile health
    Turakhia, Mintu P.
    Kaiser, Daniel W.
    [J]. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2016, 47 (01) : 45 - 50
  • [5] Mobile health technology integrated care in atrial fibrillation patients according to atrial fibrillation subtype: a subgroup analysis of the mAFA-II randomised trial
    Corica, B.
    Guo, Y.
    Romiti, G. F.
    Mei, D. A.
    Proietti, M.
    Zhang, H.
    Lip, G. Y. H.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [6] Improving outcomes with integrated care of patients with atrial fibrillation and multimorbidity using mobile health technology: a report from the mAFA II trial
    Guo, Y.
    Lip, G. Y. H.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 3114 - 3114
  • [7] Mobile health technology integrated care in older atrial fibrillation patients: a subgroup analysis of the mAFA-II randomised clinical trial
    Guo, Yutao
    Romiti, Giulio Francesco
    Proietti, Marco
    Bonini, Niccolo
    Zhang, Hui
    Lip, Gregory Y. H.
    [J]. AGE AND AGEING, 2022, 51 (11)
  • [8] The atrial fibrillation epidemic is approaching the physician's door: will mobile technology improve detection?
    Lindsberg, Perttu J.
    Toivonen, Lauri
    Diener, Hans-Christoph
    [J]. BMC MEDICINE, 2014, 12
  • [9] The atrial fibrillation epidemic is approaching the physician's door: will mobile technology improve detection?
    Perttu J Lindsberg
    Lauri Toivonen
    Hans-Christoph Diener
    [J]. BMC Medicine, 12
  • [10] Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation
    Guo, Yutao
    Wang, Hao
    Zhang, Hui
    Liu, Tong
    Liang, Zhaoguang
    Xia, Yunlong
    Yan, Li
    Xing, Yunli
    Shi, Haili
    Li, Shuyan
    Liu, Yanxia
    Liu, Fan
    Feng, Mei
    Chen, Yundai
    Lip, Gregory Y. H.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (19) : 2365 - 2375